Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)

Biao Zheng; Jianhua Qu; Kenoki Ohuchida; Haimin Feng; Stephen Jun Fei Chong; Zilong Yan; Yicui Piao; Peng Liu; Nan Sheng; Daiki Eguchi; Takao Ohtsuka; Kazuhiro Mizumoto; Zhong Liu; Shazib Pervaiz; Peng Gong; Masafumi Nakamura

doi:10.7150/thno.68023

Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)

Biao Zheng, Jianhua Qu, Kenoki Ohuchida, Haimin Feng, Stephen Jun Fei Chong, Zilong Yan, Yicui Piao, Peng Liu, Nan Sheng, Daiki Eguchi, Takao Ohtsuka, Kazuhiro Mizumoto, Zhong Liu, Shazib Pervaiz, Peng Gong, Masafumi Nakamura

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

3 被引用数 (Scopus)

抄録

In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.

本文言語	英語
ページ（範囲）	10171-10172
ページ数	2
ジャーナル	Theranostics
巻	11
号	20
DOI	https://doi.org/10.7150/thno.68023
出版ステータス	出版済み - 2021

!!!All Science Journal Classification (ASJC) codes

医学（その他）
薬理学、毒性学および薬学（その他）

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.7150/thno.68023

他のファイルとリンク

フィンガープリント

「Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Zheng, B., Qu, J., Ohuchida, K., Feng, H., Chong, S. J. F., Yan, Z., Piao, Y., Liu, P., Sheng, N., Eguchi, D., Ohtsuka, T., Mizumoto, K., Liu, Z., Pervaiz, S., Gong, P., & Nakamura, M. (2021). Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001). Theranostics, 11(20), 10171-10172. https://doi.org/10.7150/thno.68023

Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001). / Zheng, Biao; Qu, Jianhua; Ohuchida, Kenoki その他.
In: Theranostics, Vol. 11, No. 20, 2021, p. 10171-10172.

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

Zheng, B, Qu, J, Ohuchida, K, Feng, H, Chong, SJF, Yan, Z, Piao, Y, Liu, P, Sheng, N, Eguchi, D, Ohtsuka, T, Mizumoto, K, Liu, Z, Pervaiz, S, Gong, P & Nakamura, M 2021, 'Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)', Theranostics, vol. 11, no. 20, pp. 10171-10172. https://doi.org/10.7150/thno.68023

@article{8bcacde8445e426e83cd99b2150b919b,

title = "Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)",

abstract = "In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.",

author = "Biao Zheng and Jianhua Qu and Kenoki Ohuchida and Haimin Feng and Chong, {Stephen Jun Fei} and Zilong Yan and Yicui Piao and Peng Liu and Nan Sheng and Daiki Eguchi and Takao Ohtsuka and Kazuhiro Mizumoto and Zhong Liu and Shazib Pervaiz and Peng Gong and Masafumi Nakamura",

note = "Publisher Copyright: {\textcopyright} The author(s).",

year = "2021",

doi = "10.7150/thno.68023",

language = "English",

volume = "11",

pages = "10171--10172",

journal = "Theranostics",

issn = "1838-7640",

publisher = "Ivyspring International Publisher",

number = "20",

}

TY - JOUR

T1 - Erratum

T2 - LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)

AU - Zheng, Biao

AU - Qu, Jianhua

AU - Ohuchida, Kenoki

AU - Feng, Haimin

AU - Chong, Stephen Jun Fei

AU - Yan, Zilong

AU - Piao, Yicui

AU - Liu, Peng

AU - Sheng, Nan

AU - Eguchi, Daiki

AU - Ohtsuka, Takao

AU - Mizumoto, Kazuhiro

AU - Liu, Zhong

AU - Pervaiz, Shazib

AU - Gong, Peng

AU - Nakamura, Masafumi

PY - 2021

Y1 - 2021

N2 - In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.

AB - In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.

UR - http://www.scopus.com/inward/record.url?scp=85119994855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85119994855&partnerID=8YFLogxK

U2 - 10.7150/thno.68023

DO - 10.7150/thno.68023

M3 - Comment/debate

C2 - 34815810

AN - SCOPUS:85119994855

SN - 1838-7640

VL - 11

SP - 10171

EP - 10172

JO - Theranostics

JF - Theranostics

IS - 20

ER -